Caption Management’s 89bio ETNB Stock Holding History

Caption Management’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-94,400	Closed	-$1.39M	–	1717
2025 Q3	$1.39M	Sell	94,400 -571,200	-86%	-$5.82M	0.01%	990
2025 Q2	$6.54M	Buy	665,600 +308,800	+87%	+$2.56M	0.07%	322
2025 Q1	$2.59M	Sell	356,800 -75,300	-17%	-$658K	0.02%	601
2024 Q4	$3.38M	Sell	432,100 -33,400	-7%	-$275K	0.03%	511
2024 Q3	$3.44M	Sell	465,500 -9,400	-2%	-$79K	0.06%	395
2024 Q2	$3.8M	Hold	474,900	–	–	0.06%	327
2024 Q1	$5.53M	Hold	474,900	–	–	0.08%	279
2023 Q4	$5.3M	Buy	+474,900	New	+$4.37M	0.07%	312
2023 Q2	–	Sell	-353,500	Closed	-$5.38M	–	1188
2023 Q1	$5.38M	Buy	+353,500	New	+$4.61M	0.1%	215

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Caption Management's ETNB Position: Q4 2025 in Review

Caption Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 196,300 shares — an estimated $2.89M sold.

Caption Management first reported a position in ETNB in Q1 2023 and held it in 10 quarters. The position peaked at $3.97M in Q1 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Caption Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Caption Management sold 196,300 89bio shares in Q4 2025, an estimated $2.89M.
Caption Management first reported a position in 89bio in Q1 2023 and held it in 10 quarters.
Caption Management's 89bio position peaked at $3.97M in Q1 2023.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.